Please assess the completion status of the following clinical trial:

Trial Title: VANOS Cream and Skin Barrier Function

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of AD according to Hanifin-Rajka criteria (see Appendix B)~* Age 12 years or older~* Must have an Investigator's Global Assessment (IGA) Score of Moderate, Severe, or Very Severe (See Appendix C)~* Must have failed to achieve adequate disease despite adequate topical or systemic therapy~* Must be a candidate, according to the principal investigator and standard of care, for a super-potent topical steroid course. Subjects that are candidates for super-potent topical steroids are defined as subjects whose disease is not adequately controlled with medium-potency topical steroids or systemic therapy, including phototherapy.~Exclusion Criteria:~* Active skin infection~* Hypersensitivity to any ingredients in Vanos cream~* Previous use of super-potent topical steroids within 2 weeks of starting study (Class I steroid).

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vanos Cream (Type: EXPERIMENTAL): glucocorticoid cream

Based on this trial design, predict the completion outcome and termination type (if applicable).